| AMICUS THERAPEUTICS INC. |
| USA |
| Gesundheit |
| US03152W1099 / A0MSMZ |
| AM6 (Frankfurt) / FOLD (NASDAQ) |
| FRA:AM6, ETR:AM6, AM6:GR, NASDAQ:FOLD |
| - |
| https://amicusrx.com/ |
|
Amicus Therapeutics Inc. is a biotechnology company dedicated to discovering, developing, and commercializing therapies for rare and orphan diseases. It focuses on addressing unmet medical needs in genetic disorders through proprietary technology pla..
>Volltext.. |
| 3917.66 Mio. EUR |
| 4043.25 Mio. EUR |
| 548.36 Mio. EUR |
| 36.27 Mio. EUR |
| -23.44 Mio. EUR |
| -0.08 EUR |
| 382.48 Mio. EUR |
| 185.04 Mio. EUR |
| 28.66 Mio. EUR |
| 1.23 |
| 5.81% |
| 57.41% |
| - |
| - |
| - |
| AMICUS |
| 02.04.26 |
|
||||
|
||||
|